Sheel, MeruBeard, FrankQuinn, HelenDey, AKirk, MartynKoehler, Ann PMarkey, PeterMcIntyre, PeterMacartney, Kristine K.2019-11-250725-3141http://hdl.handle.net/1885/186549In 2005, the National Immunisation Program implemented a varicella vaccine for children aged 18 months, and in 2016, a herpes zoster (HZ) vaccine for adults aged 70-79 years. This epidemiological review analyses national trends in varicella and HZ for the years 1998-2015 to examine the impact of a funded varicella vaccine and provide a baseline for monitoring the impact of a funded HZ vaccine.The National Centre for Immunisation Research and Surveillance is supported by the Australian Government Department of Health, the NSW Ministry of Health and The Children’s Hospital at Westmead.application/pdfen-AU© Commonwealth of Australia 201820182019-05-19